BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37796776)

  • 21. Treatment patterns in women with urinary urgency and/or urgency urinary incontinence in the symptoms of Lower Urinary Tract Dysfunction Research Network Observational Cohort Study.
    Bretschneider CE; Liu Q; Smith AR; Kirkali Z; Amundsen CL; Lai H; Geynisman-Tan J; Kirby A; Cameron AP; Helmuth ME; Griffith JW; Jelovsek JE;
    Neurourol Urodyn; 2023 Jan; 42(1):194-204. PubMed ID: 36579974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?
    Castro-Diaz D; Cardozo L; Chapple CR; Espuña M; Kelleher C; Kirby M; Milsom I; Sievert KD; Tubaro A
    Int J Clin Pract; 2014 Mar; 68(3):356-62. PubMed ID: 24373133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).
    Kakizaki H; Lee KS; Yamamoto O; Jong JJ; Katou D; Sumarsono B; Uno S; Yamaguchi O
    Eur Urol Focus; 2020 Jul; 6(4):729-737. PubMed ID: 31718957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of bladder pressure and discomfort symptoms: How do overactive bladder differ from interstitial cystitis/bladder pain syndrome patients?
    Gousse A; Vetter J; Lai HH
    BMC Urol; 2023 Mar; 23(1):53. PubMed ID: 36997906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overactive bladder and autonomic dysfunction: Lower urinary tract symptoms in females with postural tachycardia syndrome.
    Kaufman MR; Chang-Kit L; Raj SR; Black BK; Milam DF; Reynolds WS; Biaggioni I; Robertson D; Dmochowski RR
    Neurourol Urodyn; 2017 Mar; 36(3):610-613. PubMed ID: 26859225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental Pain and Auditory Sensitivity in Overactive Bladder Syndrome: A Symptoms of the Lower Urinary Tract Dysfunction Research Network (LURN) Study.
    Harte SE; Wiseman J; Wang Y; Smith AR; Yang CC; Helmuth M; Kreder K; Kruger GH; Gillespie BW; Amundsen C; Kirkali Z; Lai HH;
    J Urol; 2022 Jan; 207(1):161-171. PubMed ID: 34428922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered gut microbiome associated with overactive bladder and daily urinary urgency.
    Okamoto T; Hatakeyama S; Imai A; Yamamoto H; Yoneyama T; Mori K; Yoneyama T; Hashimoto Y; Nakaji S; Ohyama C
    World J Urol; 2021 Mar; 39(3):847-853. PubMed ID: 32419054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Bladder Filling Rate on the Voiding Behavior of Patients with Overactive Bladder.
    Redmond EJ; O'Kelly T; Flood HD
    J Urol; 2019 Aug; 202(2):326-332. PubMed ID: 30817239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clustering of patients with overactive bladder syndrome.
    Gross J; Vetter JM; Lai HH
    BMC Urol; 2021 Mar; 21(1):41. PubMed ID: 33740925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal resting-state brain activity and connectivity of brain-bladder control network in overactive bladder syndrome.
    Biao W; Long Z; Yang Z; Hua G; Shuangkun W
    Acta Radiol; 2022 Dec; 63(12):1695-1702. PubMed ID: 34851160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship Between Central Obesity, General Obesity, Overactive Bladder Syndrome and Urinary Incontinence Among Male and Female Patients Seeking Care for Their Lower Urinary Tract Symptoms.
    Lai HH; Helmuth ME; Smith AR; Wiseman JB; Gillespie BW; Kirkali Z;
    Urology; 2019 Jan; 123():34-43. PubMed ID: 30393054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between voiding lower urinary tract symptoms and findings on dynamic magnetic resonance imaging with regard to pelvic organs and their supportive structures.
    Watanabe S; Kinno K; Takeuchi Y; Sawada Y; Sekido N
    Low Urin Tract Symptoms; 2024 Jan; 16(1):e12506. PubMed ID: 37866821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of the SARS-CV-2 virus on the urinary bladder].
    Kulchavenya EV; Shevchenko SY
    Urologiia; 2023 Mar; (1):41-45. PubMed ID: 37401682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitive or Detrusor Overactivity: Which is Associated with Filling Symptoms in Female Bladder Outlet Obstructed Patients.
    Zhang J; Cao M; Chen Y; Liang W; Liang Y
    Urol J; 2019 Jun; 16(3):285-288. PubMed ID: 30882167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total fluid intake, caffeine, and other bladder irritant avoidance among adults having urinary urgency with and without urgency incontinence: The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).
    Cameron AP; Helmuth ME; Smith AR; Lai HH; Amundsen CL; Kirkali Z; Gillespie BW; Yang CC; Clemens JQ;
    Neurourol Urodyn; 2023 Jan; 42(1):213-220. PubMed ID: 36579975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
    Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
    BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
    Cheng Y; Mansfield KJ; Allen W; Millard RJ; Burcher E; Moore KH
    Neurourol Urodyn; 2013 Sep; 32(7):969-73. PubMed ID: 23129360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.